ORKA vs VLTO · $4.27B cap vs P/E 29, rev $5.50B
Oruka Therapeutics, Inc. (ORKA) versus Veralto Corporation (VLTO) — a side-by-side from cached financials, not a winner call.
Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.
Veralto Corporation (VLTO) is a pollution & treatment controls company listed on US.
ORKA does not have a complete income-statement cache yet.
Latest reported VLTO revenue for 2025-12-31 was $5.50B. Net income was $940.0M. Revenue was up 6.0% from 2024-12-31 to 2025-12-31. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
ORKA currently screens at market cap $4.27B. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
Not investment advice. Open the ORKA and VLTO stock pages for the full models.
Not investment advice.